Fresenius Medical Care AG
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
20.64%
Market Cap
9.76 Bil.
P/E Ratio
12.13
Dividend Yield
3.66 %
Earnings per Share
3.36 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 39.79 G | 0 Units |
| PRICE DETERMINATION TIME | 06/12/2026 / 09:55:48 PM | |
| DAILY VOLUME (UNITS) | 11,161 | |
| DAILY HIGH / LOW | 39.79 | 38.6 |
| PREV. DAY'S PRICE | 38.81 | (06/11) |
| CHANGE DAY BEFORE | +0.98 | 2.53 % |
| 52 WEEK HIGH / LOW | 50.28 (06/16) | 34.58 (05/05) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 4.32 | 3.99 | 3.36 | 1.83 | 1.70 |
| DIVIDENDS PER SHARE | 1.51 | 1.39 | 1.49 | 1.44 | 1.19 |
| DIVIDEND YIELD IN % | - | - | 3.66 % | 3.26 % | 3.13 % |
| DIVIDEND GROWTH IN % | - | - | 3.47 % | 21.01 % | 6.25 % |
| PRICE - EARNINGS RATIO | 9.19 | 9.95 | 12.13 | 24.09 | 22.32 |
| PRICE - BOOK RATIO | - | - | 0.86 | 0.89 | 0.82 |
| PRICE - SALES RATIO | - | - | 0.60 | 0.67 | 0.57 |
| PRICE - CASH FLOW RATIO | - | - | 4.43 | 5.43 | 4.24 |
Master Data
| WKN | 578580 |
| ISIN | DE0005785802 |
| SYMBOL | FME |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Fresenius Medical Care |
| INDEX MEMBERSHIP | DAX |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 245.24 Mil. |
| MARKET CAPITALISATION | 9.76 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 4.03 % | 4.66 % | 0.86 % | -0.67 % | -20.64 % | -6.13 % | -41.93 % | -2.14 % |
| HIGH | 39.79 | 39.79 | 40.62 | 41.75 | 50.28 | 54.00 | 71.08 | 41.75 |
| LOW | 37.70 | 35.34 | 34.58 | 34.58 | 34.58 | 30.70 | 25.72 | 34.58 |
Dividend
per share
Company profile
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Structured products for Fresenius Medical Care AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 3 days)
06/18/26JP Morgan European Healthcare Forum
(in 50 days)
08/04/26Q2 2026 Earnings Call
(in 50 days)
08/04/26Q2 2026 Earnings Release
(in 141 days)
11/03/26Q3 2026 Earnings Call
(in 141 days)
11/03/26Q3 2026 Earnings Release